Sleep disorders in Parkinson's disease.
Sleep quality is one of the major sources of dissatisfaction among patients with Parkinson's disease (PD). Insomnia, parasomnia and daytime sleep disorders are all common. The motor problems accompanying PD are well studied and documented, yet little is known about sleep and the other non-motor problems. Dopaminergic medications, the neurochemical and neurodegenerative changes may all contribute to the pathogenesis of sleep disorders in PD. Subjective or objective sleepiness assessment should routinely be performed by physicians looking after PD patients. Patients should be informed of the risks associated with excessive daytime sleepiness. Management is difficult and should be targeted to the specific sleep disorder and its likely cause. Simple sleep measures such as sleep hygiene should be tried first before pharmacological treatment is initiated.
Abdelgabar
A
A
Department of Elderly Medicine, Princess of Wales Hospital, Grimsby, UK.
Sharma
J
J
D000978:Antiparkinson Agents / Q000009:adverse effects; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D010146:Pain / Q000209:etiology; D010300:Parkinson Disease / Q000150:complications*; D011788:Quality of Life; D012890:Sleep / Q000187:drug effects / Q000502:physiology; D012893:Sleep Wake Disorders / Q000209:etiology* / Q000628:therapy
D000978:Antiparkinson Agents; D007980:Levodopa